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Histoplasmosis, caused by two varieties of dimorphic fungi, Histoplasma capsulatum 
variant capsulatum and Histoplasma capsulatum variant duboisii is a systemic fungal 
infection. It has a worldwide distribution and is shown to be more prevalent in North 
America and Central America. Both variants occur in Africa. Disease spectrum ranges 
from asymptomatic primary infection to disseminated disease in immunocompromised 
patients. Since the upsurge of Acquired Immune Deficiency Syndrome (AIDS) and 
despite the availability of High Active Anti-Retroviral Therapy (HAART) many patients 
still present with opportunistic infections of which histoplasmosis is one.
 four cases are presented; two infants and two adults. All had disseminated disease with 
multiple organ involvement and the disease was not suspected clinically. Diagnosis 
was made incidentally on bone marrow aspirate cytology. The two adult cases were 
HIV positive, one with CD4 counts of 132 cells/microlitre and was not on HAART. 
The other was on HAART but the CD4 had not been determined. One of the infants 
tested HIV negative and the others status was unknown. A high index of suspicion 
is required for diagnosis as the disease may mimic tuberculosis(TB) and other causes 
of hepatosplenomegaly such as visceral leishmaniasis. 
 Laboratory diagnosis includes culture, direct staining, antigen and antibody detection. 
Antibody detection may give false negative in the immunocompromised patient. The 
infection responds well to antifungal agents (amphotericin B is the drug of choice) 
and life long maintenance therapy may be required in AIDS especially  if CD4 counts 
remain less than 150 cells/microlitre.
 Histoplasmosis should be a differential diagnosis in immunosuppressed patients with 
unexplained fever, weight loss, hepatosplenomegaly and chest findings especially if 
not responding to anti-TB treatment. 
INTRODuCTION 
Histoplasmosis is an endemic infection in most of 
the United States and can be found worldwide. 
The spectrum of disease ranges from asymptomatic 
infection to severe disseminated disease. Life 
threatening illness is usually associated with an 
immunocompromised state. Bone marrow, liver, skin, 
and mucocutanoeus lesions usually reveal organisms 
which may also be visualised on routine peripheral 
blood smears in patients with disseminated disease. 
Four patients all diagnosed incidentally on bone 
marrow aspirate cytology are presented. Available 
laboratory diagnostic methods and treatment options 
are reviewed. 
CASE REPORTS
Case 1: A six year old female from Machakos (Eastern 
province) with fever, cough and abdominal pain for 
five months, and had showed no response to treatment 
for tuberculosis and leishmaniasis. He was ill looking, 
pale, wasted, febrile with bilateral pitting oedema of 
the legs, hepatosplenomegaly, scattered bilateral basal 
crepitations on chest examination. There was no lymph 
node enlargement. Laboratory findings showed Hb- 7.8 
gm/dl, WBC- 7.7 x 10 9/ L( N-51, L-41, M-8), platelets- 200 
x 10 9/L, ESR-47 mm/1st hr. Liver function tests were 
within normal range(Total protein- 58 g/L( Albumin- 23, 
Globulin- 35 gm/L), Sputum was negative for Acid Fast 
Bacilli(AFB), HIV- negative, chest X-ray showed patchy 
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pneumonic infiltrate. Abdominal ultrasonography 
confirmed hepatosplenomegaly. 
Case 2: A one year nine months old female from 
Tana River District (Coast province) presented with 
anorexia, abdominal swelling and passing black 
coloured stools for two months. She was found to be in 
fair general condition, pale, with hepatosplenomegaly. 
There was no lymph node enlargement. A differential 
diagnosis of malarial splenomegaly syndrome and 
visceral leishmaniasis was made. Laboratory findings 
showed-Hb- 7.6 gm/dl,WBC- 4.6 x 109/L( N-34, L- 61, 
M-5),platelets of- 114 x 10 9/L. Blood slide for malaria 
parasite was negative. Stool for ova and cysts was also 
negative. Urine examination showed no significant 
finding. The mother declined to consent for HIV 
testing. Abdominal ultrasonography confirmed the 
hepatosplenomegaly. 
Case 3: A 49 year old male from Kitui (Eastern 
province), known HIV positive for three years, who 
presented with fever, abdominal swelling, lower 
limb swelling for five months, night sweats, weight 
loss, anorexia, malaise and body aches. He was 
found to be wasted, febrile, pale, with cervical and 
inguinal lymphnode enlargement, bilateral pitting 
pedal oedema and hepatosplenomegaly. Laboratory 
findings were Hb- 5.2 gm/dl,WBC- 5.1 x 109/L, 
platelets 6 x 109/L. Renal function tests were within 
normal range. Liver function tests showed protein 
of 53 gm/L (Albumin- 18 gm/L),AST- 94, ALT- 30, 
ALP- 214, GGT- 62, hepatitis B and C screening was 
negative. CD4 counts were 132 cells/microlitre. Chest 
X-ray was normal and abdominal ultrasonography 
showed hepatosplenomegaly. 
Case 4: A 50 year old female from central province, 
known HIV positive for six months on HAART, 
treated for TB a month previously presented with 
cough with blood stained sputum, oral ulcers, lower 
limb weakness for a month, chills, night sweats 
and anorexia. She was found to be sick looking, 
febrile wasted, drowsy with pallor and bilateral 
pedal oedema. She had submental, jugulo-digastric 
lymphnode enlargement febrile. There were multiple 
skin lesions on the trunk and extremities. There were 
left upper chest crepitations, hepatosplenomegaly 
and reduced muscle bulk globally with hypereflexia 
in the upper limbs. Laboratory findings showed 
Hb- 5.58 gm/dl,WBC- 3.6 x 109/L( N- 80, L- 11, M- 
9) and platelets of 119 x 109/L, urea, electrolytes and 
creatinine were within normal range. Liver function 
tests showed protein- 43 gm/L, albumin- 17 gm/L, 
AST- 76, ALT-14, ALP-423, GGT- 102. Hepatitis B and 
C screening were negative. 
 Chest X-ray showed left upper lobe consolidation. 
CT scan of the brain was normal and abdominal 
ultrasonography confirmed hepatosplenomegaly. 
  All the patients were started on antifungal agents 
(fluconazole or cotrimoxazole) along with supportive 
therapy. One patient(case 2) responded positively to 
treatment while two (case 1 and 4) succumbed to the 
disease and one(case 3) was lost to follow up.
DISCuSSION
Disseminated histoplasmosis is an AIDS defining illness 
caused by a dimorphic fungi Histoplasma capsulatum 
variant capsulatum, the other variant Histoplasma 
capsulatum variant dubosii which causes African 
histoplasmosis (1) is endemic in Central and West 
Africa and is rarely associated with HIV infections (2). 
Before the era of HAART, the prevalence of Histoplasma 
capsulatum variant capsulatum in HIV – infected 
patients in hyperendemic areas of South Eastern USA 
reached up to 30% (3). Other patient groups at risk 
for disseminated histoplasmosis include transplant 
recipients, those with haematologic malignancies and 
those on steroids (4). Infants may also develop severe 
life threatening infections. Two patients who had HIV 
infection in this report one had been on HAART for 
more than three months and one had CD4 counts of 
132 cells/microlitre. Patients with CD4 counts of <150 
cells/ul are most at risk. Symptoms of disseminated 
histoplasmosis include fever, malaise, anorexia and 
weight loss which were present in all the four reported 
cases. Hepatosplenomegaly and lymphadenopathy are 
also common findings. Anaemia and petechiae may be 
a finding if pancytopaenia is present.
  Only one of the patients had mucous membrane 
ulcerations as well as skin ulcers, nodules or mollusum 
like papules that are reported in some patients. In 
infants and patients with AIDS, a rapidly fatal acute 
form of disseminated severe disease can present as 
sepsis syndrome with hypertension, disseminated 
intravascular coagulation, renal failure and acute 
respiratory distress (4). In this report one adult patient 
succumbed acutely to the disease and one infant died 
after six months history of illness. 
 In a series of 164 patients with HIV and 
disseminated histoplasmosis Elizabeth et al (5) in 
Brazil showed the most frequent manifestations 
to be fever (95%), cough (75%), weight loss (72%), 
diarrhoea(61%) and adynamia (56%).
  Disseminated histoplasmosis may involve any 
organ including; Gastrointestinal tract (colon, small 
bowel with ulcerations, strictures and sometimes 
perforations); adrenal gland (patients may present with 
Addison’s disease) tongue, gingivae, buccal mucosa, 
lips, pharynx and larynx are also commonly affected 
than in any other endemic mycoses (4). Symptomatic 
disease is rare in the genitourinary tract, kidney and 
osteoarticular sites. Other rare sites include; Gall bladder, 
breast, thymus and thyroid gland and are usually 
discovered at autopsy . Other rare manifestations of 
disseminated histoplasmosis include; endocarditis and 
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vascular infection and central nervous system infection 
manifesting as meningitis and brain abscesses.
  In the immunocompetent persons exposed to H. 
capsulatum, symptomatic infection is uncommon and 
most patients have no symptoms, the disease spectrum 
varies from (i) Acute pulmonary histoplasmosis 
occurring mostly in children and is accompanied by 
rheumatologic and dermatologic manifestations. (ii) 
Chronic cavitary pulmonary histoplasmosis in older 
patients. Pre-existing chronic obstructive pulmonary 
disease, especially emphysema is usually present. 
Progressive pulmonary insufficiency usually leads 
to death. (iii) Granulomatous mediastinitis with 
massive enlargement of multiple nodes that are 
matted. Majority of patients are asymptomatic but 
others may experience pressure symptoms when the 
enlarged nodes infringe on the superior vena cava, the 
bronchii or the oesophagus (iv). Mediastinal fibrosis 
which is uncommon is frequently lethal, results from 
uncontrolled fibrotic response to infected caseous 
nodes resulting in the encasement of nodes and vital 
structures of the mediastinum. Most patients are young 
adults between the ages of 20-40 years with a slight 
predominance of women. Other manifestations include 
pericarditis, pleural disease and broncholithiasis (4).
  Bone marrow examination in disseminated 
infections, as in all the cases in this report, usually 
reveals organisms (Figure 1). The reported sensitivity of 
bone marrow fungal stains in patients with AIDS and 
histoplasmosis has ranged from 67% to 100% (6). These 
are also seen in liver, skin and mucocutaneous lesions. 
Routine peripheral blood smears will sometimes show 
yeasts within neutrophils in patients who are seriously 
ill. Tissue biopsy usually shows the distinctive 2 -4µm 
oval narrow – based budding yeasts.
figure 1
Histoplasma capsulatum yeasts in bone marrow 
macrophages
  Other organisms that may mimic the appearance 
of H. capsulatum include; Leishmania (as was the 
case with of one of the patients in this report) and 
Candida. Tissues are stained with methenamine silver 
or periodic acid schiff (PAS) stains. Yeasts are usually 
found within macrophages but can also be seen free 
in tissues.
  Other diagnostic methods include culture 
of tissue or body fluids on Sabourand’s dextrose 
agar. Growth can take up to six weeks. Definitive 
identification of H. capsulatum from other mycosis 
is made by a chemiluminescent DNA probes.
  Antigen detection from urine or serum was first 
described in 1986 using radio immunoassay is now 
performed by a sandwich enzyme immunoassay. 
In HIV patients the antigen is detected in urine in 
95% of patients and in 86% of patients in serum (7). 
Connolly et al (8) reported 100% antigen detection 
in urine and 92% detection in serum. False positive 
reactions may occur in other endemic mycoses. Work 
on PCR assays is currently ongoing.
  Antibody assays by complement fixation and 
immmunodiffusion assay are useful in patients who 
have chronic forms of histoplasmosis. False positive 
results are seen in patients with lymphoma, TB, 
sarcoidosis and other fungal infections. Assays are 
less useful in immunossupresion as these patients 
mount a poor response. Skin reagents are no longer 
commercially available. Skin tests historically are 
essential in defining areas where H. capsulatum is 
endemic but are not very helpful as a diagnostic test 
due to cross reactions with other fungi. 
  Amphoterecin B remained the drug of choice 
until 1990s when azoles were introduced. Mortality 
in those who had disseminated disease and not 
treated was 83% compared to 23% in amphotericin 
B treated patients. Introduction of ketoconazole 
enabled treatment in the out-patient setting with 
oral medication. Treatment is taken for at least six 
months. Other choices include itraconazole which 
has fewer side effects and has proved effective in 
AIDS patients, other newer azoles that have been 
tried include voriconazole and posaconazole (4).
  The length of therapy depends on severity of 
the infection and immune status. Some guidelines 
recommend 6 – 18 months in total because of high 
rate of relapse for AIDS patients. Maintenance azole 
therapy is continued for life after initial response to 
antifungal therapy especially if CD4 counts remain 
below 150cells/µl. With the use of effective HAART, 
rates of infection have fallen in the AIDS population 
and prophylaxis is no longer recommended (9).
  In summary, disseminated histoplasmosis 
should be suspected in any immunocompromised 
patient presenting with unexplained fever especially 
if severely ill. A high index of suspicion is required 
as it may mimic other illness especially tuberculosis, 
leishmaniasis and typhoid. Bone marrow examination 
even with routine stains is a useful diagnostic test 
when cultures and serological tests are unavailable.
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